Introduction
Hypertension
SECONDARY, HYPERTENSION
Clinical trials in cardiovascular medicine routinely use primary, secondary, and other endpoints to capture the breadth of an intervention’s effects. However, this can make the interpretation of trial results challenging, as an intervention’s effects can vary by outcome, including benefits and harms [The international Control of Hypertension in Pregnancy Study (CHIPS; ClinicalTrials.gov NCT01192412) [In a secondary analysis of CHIPS Trial data, we explored whether weighting outcomes to reflect patient preferences would change the interpretation of trial results.